Value-based insurance design for pharmacare

In this interview, Dr. Steve Morgan and Dr. Kai Yeung discuss a possible framework for pharmacare. They argue and explain that setting copayments based on drugs’ clinical and economic value can promote patient choice and encourage cost-conscious selections. Dr. Kai Yeung is a pharmacist and pharmaceutical economist at Kaiser Permanente Washington Health Research Institute in Seattle, Washington, and Dr. Steve Morgan is a health economist and professor of health policy at University of British Columbia, in Vancouver. They co-authored an analysis article published in the Canadian Medical Association Journal. Full article: www.cmaj.ca/lookup/doi/10.1503/cmaj.181721 ---------------------------------------------------------------------- Subscribe to CMAJ Podcasts on Apple Podcasts, iTunes, Google Play, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.